1. |
中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015). 中华心血管病杂志, 2016, 3(44): 197-211.
|
2. |
Tapson VF. Acute pulmonary embolism. N Engl J Med, 2008, 358(10): 1037-1052.
|
3. |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014, 35(43): 3033-3069k.
|
4. |
Shapiro NL, Bhatt SH. Critical Review and Update on the Treatment of Acute and Chronic Pulmonary Embolism. J Pharm Pract, 2016, 29(1): 35-45.
|
5. |
Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med, 2000, 160(6): 761-768.
|
6. |
Eichinger S. Cancer associated thrombosis: risk factors and outcomes. Thromb Res, 2016, 140: S12-17.
|
7. |
Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism-A population-based case-control study. Arch Intern Med, 2000, 160(6): 809-815.
|
8. |
Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med, 2000, 160(6): 769-774.
|
9. |
Hutten BA, Prins MH, Gent M, et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol, 2000, 18(17): 3078-3083.
|
10. |
Duan Q, Gong Z, Song H, et al. Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction. Int J Med Sci, 2012, 9(6): 453-461.
|
11. |
宋浩明, 龚朱, 王乐民, 等. 静脉血栓栓塞症患者外周血单个核细胞 T 细胞免疫功能相关基因 mRNA 表达. 中华内科杂志, 2012, 51(7): 551-553.
|
12. |
Zoller B, Li X, Sundquist J, et al. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis, 2012, 2(3): 171-183.
|
13. |
Yusuf HR, Hooper WC, Grosse SD, et al. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res, 2015, 135(1): 50-57.
|
14. |
Kabrhel C, Varraso R, Goldhaber SZ, et al. Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ, 2011, 343: d3867.
|
15. |
Burtscher M. Time spent sitting and idiopathic pulmonary embolism in women. Clin J Sport Med, 2012, 22(2): 167-168.
|
16. |
Timp JF, Braekkan SK, Versteeg HH, et al. Epidemiology of cancer-associated venous thrombosis. Blood, 2013, 122(10): 1712-1723.
|
17. |
Grau E, Real E, Medrano J, et al. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting. Thromb Res, 1999, 96(5): 335-341.
|
18. |
Schafer AI, Levine MN, Konkle BA, et al. Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program, 2003: 520-539.
|
19. |
Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost, 2012, 10(6): 1019-1025.
|